Rapid Access to Intervention Development (RAID)
NCI is requesting applications for the Rapid Access to Intervention Development (RAID) initiative. RAID will make available to academic investigators, on a competitive basis, the preclinical development contract resources of NCI's Developmental Therapeutics Program (DTP). The goal of RAID is the rapid movement of novel molecules and concepts from the laboratory to the clinic for proof-of-principle clinical trials. Possible tasks may include production, bulk supply, goods manufacturing, process manufacturing, formulation, and toxicology. Suitable agents for RAID will include small molecules, biologics, or vaccines.
For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2123
Inquiries: RAID, Office of Associate Director, email@example.com
Midcareer Investigator Award in Patient-Oriented Research (K24)
This award will provide support for clinician investigators to allow them protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows, and/or junior clinical faculty. This award is primarily intended for clinician investigators who are at the Associate Professor level or are functioning at that rank in an academic or equivalent nonacademic setting, and who have an established record of independent, peer-reviewed Federal or private research grant funding in POR.
The PA will use the K24 award mechanism.
For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2120
Inquiries: Dr. Lester Gorelic, firstname.lastname@example.org
Cross-Disciplinary Translational Research at NIH
NCI joins the National Institute on Drug Abuse to invite applications for research that will have a practical impact on the treatment and prevention of drug abuse through the development of new research technologies that are based on existing basic and/or clinical research knowledge and technology transfer knowledge. This PA is intended to encourage projects that provide tools and resources that serve as platforms for the development of effective prevention and treatment strategies.
This PA will use the NIH research project grant (R01), small grant (R03), and exploratory/developmental (R21) award mechanisms.
For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2122
Inquiries: Dr. Jacqueline Stoddard, email@example.com